EFFECT OF FOOD BASED NUTRITION INTERVENTION; PROLCARMIV ON MANAGEMENT OF NONCOMMUNICABLE DISEASES AMONG PEOPLE LIVING WITH HIV IN BUSIA, KENYA

Abstract

Good Nutrition optimizes benefits of ART and increases treatment adherence, both prolongs lives of PLHIV (NASCOP, 2014), without proper care and management it exposes them to non-communicable diseases (NCDs). Key objective; To determine the effect of food-based nutrition intervention on the management of NCDs among PLHIV in Busia. Design was experimental using randomized control trial approach. Control group- 30 subjects fed on Plumpy ‘nut while treatment group – 30 subjects fed on Power Porridge (PROLCARMIV), for 60 days. Subjects purposively selected from the Comprehensive Care Clinic (CCC) in Busia County referral hospital- Kenya, further randomly selected using simple random sampling, assigned equally to each group. Data collected using a structured questionnaire analyzed using Social Package for Statistical Sciences version 26. Prevalence of NCDS; 75.5% hypertension; 15.6% Diabetes and 8.9% heart disease; post-intervention BMI for intervention group increased; Laboratory analyses; Hb post–intervention results; mean levels were higher in intervention group (M=13.62, SD=2.69) p-value = 0.487 compared to control group (12.69, SD=1.24), p value= 0.471. RBS were higher in control group (5.96, SD=1.70), p value= <0.001, intervention group (M=5.79, SD=1.02), p-value = <0.001. Post-intervention liver function test; TB, AST, and ALT showed higher SD indicating variability. Lipid profile; showed TC mean (4.39 (0.95) for control group; a mean 3.78(0.94) intervention group: p=0.017; HDL -control group mean 1.58(0.57): 1.14 (0.53) intervention group p=0.036: TG - control group mean 1.50 (0.50): intervention group p= 0.017: mean 1.14: (0.46): LDL mean 2.26 (0.66) control group: 1.43 (0.42): intervention group p= 0.041: all exhibited significant decreases. Kidney function tests; no significant differences between the two groups. Conclusion; Compliance for PROLCARMIV; 82.5%, attracting uptake of CCC services. PROLCARMIV can manage NCDs among PLHIV, answering the alternative hypothesis, this would inform Policy.